Candesartan upregulates angiotensin-converting enzyme 2 in kidneys of male animals by decreased ubiquitination
Description
Candesartan is a common angiotensin-II receptor-1 blocker used for patients with cardiovascular and renal diseases. Angiotensin-converting enzyme 2 (ACE2) is a negative regulator of blood pressure (BP), and also a major receptor for coronaviruses. To
